PASC - Meeting 12 April 2017

Medical Services Advisory Committee - Applications Considered

1372.1 - MRI for patients with colorectal carcinoma (CRC) with suspected hepatic metastases or patients with suspected hepatocellular carcinoma (HCC) for the purposes of staging

1376.1 - 70 gene signature (MammaPrint) for use in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit

1455 - Proton Beam Therapy for patients supported under the Medical Treatment Overseas Program

1464 - Breast Magnetic Resonance Imaging for improved definition of the breast cancer primary

1466 - Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration

1467 - Obstetric MRI

1468 - SIR-Spheres for the treatment of hepatic metastases, and other indications not listed on the MBS

1473 - A 50 gene signature assay for predicting breast cancer recurrence

1475 - Ablative fractional laser resurfacing for burn scar treatment

1476 - Genetic testing for childhood syndromes

1483 - Micro-bypass stenting for open-angle glaucoma
1496 - Micro-bypass stenting for open-angle glaucoma (external to Schlemm's canal)